1. Volume 65, Issue 3, Pages 532-542 (September 2016)
Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury 
Inmaculada Medina-Caliz, Mercedes Robles-Diaz, Beatriz Garcia-Muñoz, Camilla Stephens, Aida Ortega-Alonso, Miren Garcia-Cortes, Andres González-Jimenez, Judith A. Sanabria-Cabrera, Inmaculada Moreno, M. Carmen Fernandez, Manuel Romero-Gomez, Jose M. Navarro, Ana Mª Barriocanal, Eva Montane, Hacibe Hallal, Sonia Blanco, German Soriano, Eva M. Roman, Elena Gómez-Dominguez, Agustin Castiella, Eva M. Zapata, Miguel Jimenez-Perez, Jose M. Moreno, Ana Aldea-Perona, Manuel Hernández-Guerra, Martin Prieto, Miguel E. Zoubek, Neil Kaplowitz, M. Isabel Lucena, Raul J. Andrade 
Journal of Hepatology 
Volume 65, Issue 3, Pages (September 2016)
DOI: /j.jhep
Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

2. Fig. 1 Flow chart of the study cohort.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

3. Fig. 2
Time to liver injury resolution in 285 patients with acute idiosyncratic drug-induced liver injury who recovered classified by type of damage. An additional 13 patients (not included) had not recovered after 3years. Chol, cholestatic; HC, hepatocellular; Mix, mixed.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

4. Fig. 3
Median of ALP, ALT and TB values during the first year from DILI onset in acute and chronic groups. Each time interval includes 15days.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

5. Journal of Hepatology 2016 65, 532-542DOI: (10. 1016/j. jhep. 2016. 05
Copyright © 2016 European Association for the Study of the Liver Terms and Conditions